Table 10.

Use of intravitreal steroids for diabetic retinopathy in pregnancy

Study	Type of IV steroid	Improvement in BCVA	Improvement in CFT	Adverse effect
Fazelat et al.[70] (2 eyes of 1 patient)	0.05 ml of 40 mg/ml of Triamcinolone acetonide	Before OU – 20/40 After RE – 20/20 LE – 20/25	Before RE – 578±5µ LE – 667±8µ After RE – 159±5µ LE – 202±6µ	Nil
Concillado et al.[71] z(10 eyes of 5 patients)	700 µgm of slow-release dexamethasone implant (Ozurdex)	Before Mean ETDRS letters - 63 (Range 50-77) After Increase of ≥5 ETDRS letters	Before Mean CFT: 535 µm (range: 239-727 µm) After >145 µm reduction in CFT	Transient increase in IOP in 3/8 eyes

IV= Intravitreal; ETDRS=Early Treatment Diabetic Retinopathy Treatment Study; BCVA=Best-corrected visual acuity; CFT=Central foveal thickness; IOP=Intraocular pressure